Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank63
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P63
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025-16.48%
2024-24.36%
2023-90.07%
2022-52.23%
2021-30.44%
202019.17%
2019-106.96%
20180.00%
20170.00%